A brand team with an injectable hormonal therapy indicated for the treatment of advanced prostate cancer was experiencing lackluster brand performance with key payer, integrated delivery network (IDN), and large community urology group practices. In the crowded…
More often than ever before, we hear our pharma clients discussing hooking up with technology companies, from a digital health start-up to players like Amazon, IBM, Google, Apple, or any of the other obvious and usual suspects. You’ve probably seen …
To date, medication therapy management (MTM) services have largely been delivered by plans in a “check the box only” mode to satisfy rather low-expectation CMS Part D requirements. That expectation is beginning to shift as CMS moves from emphasizing outcomes …
